CD8A and colorectal carcinoma: Moreover, in a co-culture cell model, the antitumor immune effect of RGE occurred by enhancing hPD-1 tumor-infiltrated CD8+ T cell activity and killing hPD-L1 MC38 CRC cells with non-toxic doses of hPD-1+CD8+ T cells.